{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:31:41Z","timestamp":1793291501185,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.jaad.2015.11.012","type":"journal-article","created":{"date-parts":[[2016,7,20]],"date-time":"2016-07-20T01:22:25Z","timestamp":1468977745000},"page":"420-427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Cutaneous skeletal hypophosphatemia syndrome (CSHS) is a multilineage somatic mosaic RASopathy"],"prefix":"10.1016","volume":"75","author":[{"given":"Young H.","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Ovejero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina M.","family":"Derrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith A.","family":"Choate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jaad.2015.11.012_bib1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrg3424","article-title":"A genomic view of mosaicism and human disease","volume":"14","author":"Biesecker","year":"2013","journal-title":"Nat Rev Genet"},{"issue":"7","key":"10.1016\/j.jaad.2015.11.012_bib2","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/ng.2316","article-title":"Postzygotic HRAS\u00a0and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome","volume":"44","author":"Groesser","year":"2012","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.jaad.2015.11.012_bib3","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/jid.2012.379","article-title":"Whole-exome sequencing reveals somatic mutations in HRAS and KRAS, which cause nevus sebaceus","volume":"133","author":"Levinsohn","year":"2013","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2015.11.012_bib4","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/jid.2013.429","article-title":"NRAS mutation is the\u00a0sole recurrent somatic mutation in large congenital melanocytic nevi","volume":"134","author":"Charbel","year":"2014","journal-title":"J Invest Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2015.11.012_bib5","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1038\/jid.2013.24","article-title":"Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell","volume":"133","author":"Groesser","year":"2013","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2015.11.012_bib6","first-page":"251","article-title":"Epidermal nevus syndrome with multiple vascular hamartomas and malformations","volume":"125","author":"Calzavara Pinton","year":"1990","journal-title":"G Ital Dermatol Venereol"},{"issue":"10","key":"10.1016\/j.jaad.2015.11.012_bib7","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.braindev.2012.03.003","article-title":"A severe form of epidermal nevus syndrome associated with brainstem and cerebellar malformations and neonatal medulloblastoma","volume":"34","author":"Okumura","year":"2012","journal-title":"Brain Dev"},{"issue":"5","key":"10.1016\/j.jaad.2015.11.012_bib8","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1365-4632.2011.05034.x","article-title":"Concurrence of linear epidermal nevus and nevus flammeus in a man with optic pathway glioma: coincidence or phacomatosis?","volume":"51","author":"Seifert","year":"2012","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2015.11.012_bib9","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1346-8138.1997.tb02744.x","article-title":"Epidermal nevus syndrome with hemangioma simplex","volume":"24","author":"Kawachi","year":"1997","journal-title":"J\u00a0Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2015.11.012_bib10","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1346-8138.2003.tb00365.x","article-title":"Becker's nevus with ipsilateral breast hypoplasia: improvement with spironolactone","volume":"30","author":"Hoon Jung","year":"2003","journal-title":"J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2015.11.012_bib11","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1055\/s-0029-1213358","article-title":"Clinical contribution to symptomatology of phacomatosis","volume":"87","author":"Schimmelpenning","year":"1957","journal-title":"Fortschr Geb Rontgenstr Nuklearmed"},{"issue":"2","key":"10.1016\/j.jaad.2015.11.012_bib12","first-page":"211","article-title":"Epidermal nevus syndrome: a review and case report","volume":"43","author":"Losee","year":"1999","journal-title":"Ann Plast Surg"},{"issue":"2","key":"10.1016\/j.jaad.2015.11.012_bib13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/ddt429","article-title":"Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia","volume":"23","author":"Lim","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.jaad.2015.11.012_bib14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0022-3476(77)80444-7","article-title":"Vitamin D-resistant rickets associated with epidermal nevus syndrome: demonstration of a phosphaturic substance in the dermal lesions","volume":"91","author":"Aschinberg","year":"1977","journal-title":"J Pediatr"},{"issue":"12","key":"10.1016\/j.jaad.2015.11.012_bib15","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/archderm.1997.03890480077011","article-title":"Hypophosphatemic vitamin D-resistant rickets, precocious puberty, and the epidermal nevus syndrome","volume":"133","author":"Ivker","year":"1997","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2015.11.012_bib16","first-page":"233","article-title":"Pediatric reference values for calcium, magnesium and inorganic phosphorus in serum obtained from Bhattacharya plots for data from unselected patients","volume":"24","author":"de Kieviet","year":"1986","journal-title":"J Clin Chem Clin Biochem"},{"issue":"5","key":"10.1016\/j.jaad.2015.11.012_bib17","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1046\/j.1365-2133.2003.05273.x","article-title":"Phacomatosis pigmentokeratotica associated with hypophosphatemic vitamin D-resistant rickets: improvement in phosphate homeostasis after partial laser ablation","volume":"148","author":"Saraswat","year":"2003","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2015.11.012_bib18","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/S0022-3476(86)80283-9","article-title":"Hypophosphatemic rickets\/osteomalacia in linear sebaceous nevus syndrome: a variant of tumor-induced osteomalacia","volume":"109","author":"Carey","year":"1986","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.jaad.2015.11.012_bib19","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00467-011-2086-4","article-title":"Linear nevus sebaceous syndrome with hypophosphatemic rickets with elevated FGF-23","volume":"27","author":"Narazaki","year":"2012","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1016\/j.jaad.2015.11.012_bib20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/ijos.2015.1","article-title":"Fibroblast growth factor 23 and bone mineralization","volume":"7","author":"Guo","year":"2015","journal-title":"Int J Oral Sci"},{"issue":"11","key":"10.1016\/j.jaad.2015.11.012_bib21","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrendo.2009.196","article-title":"The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis","volume":"5","author":"Razzaque","year":"2009","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"10.1016\/j.jaad.2015.11.012_bib22","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","article-title":"FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting","volume":"112","author":"Riminucci","year":"2003","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.jaad.2015.11.012_bib23","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism","volume":"113","author":"Shimada","year":"2004","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.jaad.2015.11.012_bib24","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1210\/en.2004-0233","article-title":"Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a\u00a0putative role for parathyroid hormone in renal phosphate wasting disorders","volume":"145","author":"Bai","year":"2004","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.jaad.2015.11.012_bib25","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.berh.2011.10.020","article-title":"Miscellaneous non-inflammatory musculoskeletal conditions. Hyperphosphatemic familial tumoral calcinosis (FGF23, GALNT3 and alphaKlotho)","volume":"25","author":"Farrow","year":"2011","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.jaad.2015.11.012_bib26","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev-genom-091212-153523","article-title":"The RASopathies","volume":"14","author":"Rauen","year":"2013","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"4","key":"10.1016\/j.jaad.2015.11.012_bib27","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrc2109","article-title":"Hyperactive Ras in developmental disorders and cancer","volume":"7","author":"Schubbert","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"228","key":"10.1016\/j.jaad.2015.11.012_bib28","doi-asserted-by":"crossref","first-page":"pe17","DOI":"10.1126\/stke.2282004pe17","article-title":"Promotion and attenuation of FGF signaling through the Ras-MAPK pathway","volume":"2004","author":"Tsang","year":"2004","journal-title":"Sci STKE"},{"issue":"3","key":"10.1016\/j.jaad.2015.11.012_bib29","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nm0306-283","article-title":"Stops along the RAS pathway in human genetic disease","volume":"12","author":"Bentires-Alj","year":"2006","journal-title":"Nat Med"},{"issue":"21","key":"10.1016\/j.jaad.2015.11.012_bib30","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.1128\/MCB.01549-08","article-title":"Extracellular signal-regulated kinase 1 (ERK1) and ERK2 play essential roles in osteoblast differentiation and in supporting osteoclastogenesis","volume":"29","author":"Matsushita","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jaad.2015.11.012_bib31","doi-asserted-by":"crossref","first-page":"14003","DOI":"10.1038\/boneres.2014.3","article-title":"Role of FGF\/FGFR signaling in skeletal development and homeostasis: learning from mouse models","volume":"2","author":"Su","year":"2014","journal-title":"Bone Res"},{"issue":"33","key":"10.1016\/j.jaad.2015.11.012_bib32","doi-asserted-by":"crossref","first-page":"28087","DOI":"10.1074\/jbc.M112.377218","article-title":"Reactivation of mitogen-activated protein kinase (MAPK) pathway by FGF receptor 3 (FGFR3)\/Ras mediates resistance to vemurafenib in human B-RAF V600E mutant melanoma","volume":"287","author":"Yadav","year":"2012","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.jaad.2015.11.012_bib33","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1002\/jcb.24160","article-title":"Fibroblast growth factor-2 promotes catabolism via FGFR1-Ras-Raf-MEK1\/2-ERK1\/2 axis that coordinates with the PKCdelta pathway in human articular chondrocytes","volume":"113","author":"Yan","year":"2012","journal-title":"J Cell Biochem"},{"issue":"2","key":"10.1016\/j.jaad.2015.11.012_bib34","doi-asserted-by":"crossref","first-page":"e57322","DOI":"10.1371\/journal.pone.0057322","article-title":"Antibody-mediated activation of FGFR1 induces FGF23 production and hypophosphatemia","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jaad.2015.11.012_bib35","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/jbmr.1810","article-title":"Pharmacological inhibition of fibroblast growth factor (FGF) receptor signaling ameliorates FGF23-mediated hypophosphatemic rickets","volume":"28","author":"Wohrle","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"4","key":"10.1016\/j.jaad.2015.11.012_bib36","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/path.4465","article-title":"Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumor","volume":"235","author":"Lee","year":"2015","journal-title":"J Pathol"},{"key":"10.1016\/j.jaad.2015.11.012_bib37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev.med.051308.111339","article-title":"Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23","volume":"61","author":"Bergwitz","year":"2010","journal-title":"Annu Rev Med"},{"issue":"5","key":"10.1016\/j.jaad.2015.11.012_bib38","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrendo.2011.218","article-title":"Skeletal secretion of FGF-23 regulates phosphate and\u00a0vitamin D metabolism","volume":"8","author":"Quarles","year":"2012","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"10.1016\/j.jaad.2015.11.012_bib39","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s00223-010-9355-2","article-title":"Autocrine\/paracrine action of vitamin D on FGF23 expression in cultured rat osteoblasts","volume":"86","author":"Tang","year":"2010","journal-title":"Calcif Tissue Int"},{"issue":"12","key":"10.1016\/j.jaad.2015.11.012_bib40","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1172\/JCI29463","article-title":"Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts","volume":"116","author":"Masuyama","year":"2006","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.jaad.2015.11.012_bib41","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/hmg\/ddt455","article-title":"Abnormal Ras signaling in Costello syndrome (CS) negatively regulates enamel formation","volume":"23","author":"Goodwin","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jaad.2015.11.012_bib42","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1017\/S1462399408000902","article-title":"Noonan, Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway","volume":"10","author":"Tidyman","year":"2008","journal-title":"Expert Rev Mol Med"},{"issue":"7280","key":"10.1016\/j.jaad.2015.11.012_bib43","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nature08702","article-title":"Interaction between Ras(V12) and scribbled clones induces tumor growth and invasion","volume":"463","author":"Wu","year":"2010","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jaad.2015.11.012_bib44","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000070948","article-title":"Schimmelpenning-Feuerstein-Mims syndrome with hypophosphatemic rickets","volume":"207","author":"Zutt","year":"2003","journal-title":"Dermatology"},{"issue":"3","key":"10.1016\/j.jaad.2015.11.012_bib45","doi-asserted-by":"crossref","first-page":"135","DOI":"10.18632\/oncotarget.240","article-title":"Ras\/Raf\/MEK\/ERK and PI3K\/PTEN\/Akt\/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health","volume":"2","author":"Chappell","year":"2011","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.jaad.2015.11.012_bib46","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1200\/JCO.1999.17.11.3631","article-title":"Ras protein farnesyltransferase: a strategic target for anticancer therapeutic development","volume":"17","author":"Rowinsky","year":"1999","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.jaad.2015.11.012_bib47","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1172\/JCI72829","article-title":"Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia","volume":"124","author":"Carpenter","year":"2014","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.jaad.2015.11.012_bib48","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1210\/jc.2015-1551","article-title":"Prolonged correction of serum phosphorus in adults with X-linked hypophosphatemia using monthly doses of KRN23","volume":"100","author":"Imel","year":"2015","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962215024779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962215024779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:37:49Z","timestamp":1759271869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962215024779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0190962215024779"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2015.11.012","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous skeletal hypophosphatemia syndrome (CSHS) is a multilineage somatic mosaic RASopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2015.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}